Related Experiment Videos
[Population-based cancer registration in Germany. Essentials and perspectives]
1Universität Lübeck, Lübeck. alexander.katalinic@krebsregister-sh.de
Summary
Germany established population-based cancer registries nationwide following federal law. While completeness improved, data usability for cancer research and early detection programs remains a focus.
Area of Science:
- Public Health
- Epidemiology
- Cancer Research
Background:
- Historically, Germany lacked comprehensive population-based cancer registration across all regions.
- A federal law on cancer registration (KRG) enacted between 1995-1999 mandated establishment of registries in all federal states.
Purpose of the Study:
- To assess the development and current status of population-based cancer registries in Germany.
- To highlight improvements in completeness and identify remaining challenges.
- To emphasize the potential and need for utilizing cancer registry data in research.
Main Methods:
- Review of the implementation of the federal cancer registration law (KRG).
- Analysis of the development of 16 different cancer registry models across German federal states.
- Evaluation of improvements in registration completeness and data availability.
Main Results:
- All German federal states now have legally established population-based cancer registries.
- Cancer registration completeness has significantly improved, with several registries achieving high coverage.
- Despite uniformity in the KRG model, 16 distinct registry implementations exist, leading to heterogeneity.
- Deficits persist due to incompatible state-level registry laws, impacting data usability.
Conclusions:
- Germany has made substantial progress in establishing nationwide cancer registries, enhancing public reporting and research support.
- Future efforts must shift from registry development to optimizing the usability of cancer registry data for epidemiological studies and public health interventions.
- Cancer registry data holds significant potential for research into cancer etiology and the evaluation of early detection programs.